Plasma levels of heart failure biomarkers are primarily a reflection of extracardiac production
Weijie Du(Jilin Medical University), Herman H.W. Silljé(University Medical Center Groningen), Cees W. A. van de Kolk(University Medical Center Groningen), Adriaan A. Voors(University Medical Center Groningen), Alexandre Mebazaa(Marqueurs cardiovasculaires en situation de stress), Elisabeth M. Schouten(University Medical Center Groningen), Arnold Piek(University Medical Center Groningen), Christian Mueller(Immutep (Germany)), Rudolf A. de Boer(Erasmus MC)
Cited by 95
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008
|European Journal of Heart Failure|2008|3.5k